<i>In vivo</i> studies have shown that three months after infection, matrine can exert an anti-infection effect in the middle and late stages of alveolar echinococcosis by increasing the diversity of intestinal microbiota and the number of CD8<sup>+</sup> T cells. The gene discussed is CD8A; the disease is infection.